The use of hepatitis C virus (HCV)‐positive organs in liver transplantation (LT) has
increased in the era of direct‐acting antiviral therapy. A rising demand for organs, the …

Background: Given the high mortality rate for patients with end-stage kidney disease
receiving dialysis and the efficacy and safety of hepatitis C virus (HCV) treatments …

Given the scarcity of donated organs and the frequency of death on the waiting list,
strategies that could improve the available supply of high‐quality liver grafts are much …

Breakthroughs in hepatitis C virus (HCV) treatment and rising rates of intravenous drug use
have led to an increase in the number of organ donors who are HCV antibody–positive but …

The development and publication of this guideline were supported by KDIGO. The opinions
or views expressed in this professional education supplement are those of the authors and …

Anecdotal reports have suggested that transplantation of hepatitis C virus (HCV) antibody
positive (Ab+)/nucleic acid test negative (NAT−) donor kidneys into HCV negative recipients …

BACKGROUND Hepatitis C virus (HCV) donors should be categorized as HCV-viremic
(antibody [Ab] negative or positive/Nucleic Acid testing [NAT] positive) or HCV Ab+ …

Several single-center reports of using HCV-viremic organs for HCV-uninfected (HCV-)
recipients were recently published. We sought to characterize national utilization of HCV …

The United States opioid use epidemic over the past decade has coincided with an increase
in hepatitis C virus (HCV) positive donors. Using propensity score matching, and the Organ …

Results Among 225,479 kidneys recovered from 2005 to 2019, 5% were from HCV
seropositive donors. Compared with HCV seronegative kidneys, the odds of HCV …